Page last updated: 2024-10-26

racemetirosine and Myocardial Ischemia

racemetirosine has been researched along with Myocardial Ischemia in 2 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research Excerpts

ExcerptRelevanceReference
"The latest evidence suggests that cytokine storm syndrome (CSS) is an important cause of the transition from mild to critical pneumonia and critically ill patients' death."2.66Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury. ( Chen, SL; Zhang, DM, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhang, DM1
Chen, SL1
Takasaki, Y1
Adachi, N1
Dote, K1
Tsubota, S1
Yorozuya, T1
Arai, T1

Reviews

1 review available for racemetirosine and Myocardial Ischemia

ArticleYear
Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23

    Topics: alpha-Methyltyrosine; Angiotensin-Converting Enzyme 2; Antibodies, Monoclonal, Humanized; Antioxidan

2020

Other Studies

1 other study available for racemetirosine and Myocardial Ischemia

ArticleYear
Ischemic preconditioning suppresses the noradrenaline turnover in the rat heart.
    Cardiovascular research, 1998, Volume: 39, Issue:2

    Topics: alpha-Methyltyrosine; Animals; Enzyme Inhibitors; Heart; Ischemic Preconditioning, Myocardial; Male;

1998